Kendle opts for MetricStream for compliance management

By Staff Reporter

- Last updated on GMT

Related tags Contract research organization

Trials contractor Kendle International will use a management platform developed by US software group MetricStream to help control its global compliance and quality assurance operations.

Conducting clinical trials at multiple sites in multiple countries is now common practice in the drug development sector.

While such multi-site programmes are thought to help reduce the cost of trials by, for example, boosting patient recruitment rates, they are often more difficult to manage because they and involve complying with differing rules set out my regulatory bodies in a number of countries.

As a result, contract research organisations (CRO) are increasingly turning to third-party firms to help manage the complex compliance and reporting regulations, with Kendle’s accord with MetricStream being just the latest example.

Under the new deal, Kendle will employ MetricStream’s audit management software to automate the tracking of compliance and quality assurance events across its global trials programme.

A key feature will be use of “risk-based” management to streamline Kendle’s clinical quality assurance activities, from periodic and ad-hoc audit schedules through the tracking of observations, recommendations and the resulting responses.

Kendle will also use MetricStream’s corrective action/preventative action (CAPA) software to monitor the effective implementation of corrective measures as and when they are necessary.

The web-based software will be accessible by Kendle’s 3,600-strong workforce of research employees which, the CRO believes, will allow it to respond to the constantly evolving global regulatory environment.

Christopher Bergen, Kendle’s chief administrative officer explained that: “Critical initiatives, such as the MetricStream implementation, enhance Kendle’s ability to anticipate and respond to the constantly changing environment in which we operate.

He also suggested that the system “[will] improve cycle times for our clients, as well as reducing regulatory liabilities, risks, and costs for Kendle​.”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more